Delcath Systems Inc - Company & Market Research Reports

Delcath is a pharmaceutical company with a focus on producing medication for oncology. Their drug Melphalan Hydrochloride with the Delcath Hepatic Delivery System (Melphalan/HDS) is used to deliver high doses of chemotherapy to the liver. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In April 2012, we obtained authorization to affix a CE Mark for the Generation Two CHEMOSAT system.

From
From
From
From
From
From
From
From
From
Biliary Tumor - Pipeline Insight, 2018 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
Uveal Melanoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 235 Pages
From
Uveal Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 185 Pages
From
Uveal Melanoma - Pipeline Insight, 2018 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hemophilia B - Pipeline Insight, 2018 - Product Thumbnail Image

Hemophilia B - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
Loading Indicator
adroll